Creative Planning’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-187,029
| Closed | -$1.33M | – | 1943 |
|
|
2020
Q1 | $1.33M | Buy |
187,029
+590
| +0.3% | +$4.21K | ﹤0.01% | 543 |
|
|
2019
Q4 | $4.45M | Buy |
186,439
+248
| +0.1% | +$5.92K | 0.01% | 316 |
|
|
2019
Q3 | $4.99M | Sell |
186,191
-16,297
| -8% | -$437K | 0.02% | 284 |
|
|
2019
Q2 | $5.49M | Sell |
202,488
-125,272
| -38% | -$3.4M | 0.02% | 270 |
|
|
2019
Q1 | $11.4M | Buy |
327,760
+24,860
| +8% | +$863K | 0.04% | 147 |
|
|
2018
Q4 | $5.91M | Buy |
302,900
+85,943
| +40% | +$1.68M | 0.02% | 210 |
|
|
2018
Q3 | $5.78M | Buy |
216,957
+82,055
| +61% | +$2.19M | 0.02% | 242 |
|
|
2018
Q2 | $5.1M | Buy |
134,902
+81,202
| +151% | +$3.07M | 0.02% | 250 |
|
|
2018
Q1 | $1.75M | Buy |
53,700
+14,434
| +37% | +$471K | 0.01% | 498 |
|
|
2017
Q4 | $1.91M | Sell |
39,266
-1,160
| -3% | -$56.5K | 0.01% | 470 |
|
|
2017
Q3 | $2.18M | Buy |
40,426
+2,343
| +6% | +$127K | 0.01% | 432 |
|
|
2017
Q2 | $2.14M | Sell |
38,083
-5,790
| -13% | -$325K | 0.01% | 419 |
|
|
2017
Q1 | $1.72M | Sell |
43,873
-9,070
| -17% | -$355K | 0.01% | 474 |
|
|
2016
Q4 | $1.19M | Buy |
52,943
+30,393
| +135% | +$682K | 0.01% | 564 |
|
|
2016
Q3 | $512K | Buy |
22,550
+1,500
| +7% | +$34.1K | ﹤0.01% | 876 |
|
|
2016
Q2 | $497K | Buy |
21,050
+4,755
| +29% | +$112K | ﹤0.01% | 780 |
|
|
2016
Q1 | $332K | Sell |
16,295
-1,755
| -10% | -$35.8K | ﹤0.01% | 934 |
|
|
2015
Q4 | $929K | Buy |
18,050
+300
| +2% | +$15.4K | 0.01% | 524 |
|
|
2015
Q3 | $757K | Sell |
17,750
-1,055
| -6% | -$45K | 0.01% | 571 |
|
|
2015
Q2 | $857K | Buy |
18,805
+18,205
| +3,034% | +$830K | 0.01% | 512 |
|
|
2015
Q1 | $23K | Buy |
+600
| New | +$23K | ﹤0.01% | 2602 |
|